380 related articles for article (PubMed ID: 32818625)
1. Germline genetic variability in pancreatic cancer risk and prognosis.
Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
[TBL] [Abstract][Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
3. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
[TBL] [Abstract][Full Text] [Related]
4. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
Karakaxas D; Gazouli M; Coker A; Agalianos C; Papanikolaou IS; Patapis P; Liakakos T; Dervenis C
Med Oncol; 2014 Oct; 31(10):241. PubMed ID: 25213764
[TBL] [Abstract][Full Text] [Related]
6. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
[TBL] [Abstract][Full Text] [Related]
7. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Roberts NJ; Norris AL; Petersen GM; Bondy ML; Brand R; Gallinger S; Kurtz RC; Olson SH; Rustgi AK; Schwartz AG; Stoffel E; Syngal S; Zogopoulos G; Ali SZ; Axilbund J; Chaffee KG; Chen YC; Cote ML; Childs EJ; Douville C; Goes FS; Herman JM; Iacobuzio-Donahue C; Kramer M; Makohon-Moore A; McCombie RW; McMahon KW; Niknafs N; Parla J; Pirooznia M; Potash JB; Rhim AD; Smith AL; Wang Y; Wolfgang CL; Wood LD; Zandi PP; Goggins M; Karchin R; Eshleman JR; Papadopoulos N; Kinzler KW; Vogelstein B; Hruban RH; Klein AP
Cancer Discov; 2016 Feb; 6(2):166-75. PubMed ID: 26658419
[TBL] [Abstract][Full Text] [Related]
8. Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma.
Pistoni L; Gentiluomo M; Lu Y; López de Maturana E; Hlavac V; Vanella G; Darvasi E; Milanetto AC; Oliverius M; Vashist Y; Di Leo M; Mohelnikova-Duchonova B; Talar-Wojnarowska R; Gheorghe C; Petrone MC; Strobel O; Arcidiacono PG; Vodickova L; Szentesi A; Capurso G; Gajdán L; Malleo G; Theodoropoulos GE; Basso D; Soucek P; Brenner H; Lawlor RT; Morelli L; Ivanauskas A; ; Kauffmann EF; Macauda A; Gazouli M; Archibugi L; Nentwich M; Loveček M; Cavestro GM; Vodicka P; Landi S; Tavano F; Sperti C; Hackert T; Kupcinskas J; Pezzilli R; Andriulli A; Pollina L; Kreivenaite E; Gioffreda D; Jamroziak K; Hegyi P; Izbicki JR; Testoni SGG; Zuppardo RA; Bozzato D; Neoptolemos JP; Malats N; Canzian F; Campa D
Carcinogenesis; 2021 Aug; 42(8):1037-1045. PubMed ID: 34216462
[TBL] [Abstract][Full Text] [Related]
9. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
[TBL] [Abstract][Full Text] [Related]
10. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study.
; Haycock PC; Burgess S; Nounu A; Zheng J; Okoli GN; Bowden J; Wade KH; Timpson NJ; Evans DM; Willeit P; Aviv A; Gaunt TR; Hemani G; Mangino M; Ellis HP; Kurian KM; Pooley KA; Eeles RA; Lee JE; Fang S; Chen WV; Law MH; Bowdler LM; Iles MM; Yang Q; Worrall BB; Markus HS; Hung RJ; Amos CI; Spurdle AB; Thompson DJ; O'Mara TA; Wolpin B; Amundadottir L; Stolzenberg-Solomon R; Trichopoulou A; Onland-Moret NC; Lund E; Duell EJ; Canzian F; Severi G; Overvad K; Gunter MJ; Tumino R; Svenson U; van Rij A; Baas AF; Bown MJ; Samani NJ; van t'Hof FNG; Tromp G; Jones GT; Kuivaniemi H; Elmore JR; Johansson M; Mckay J; Scelo G; Carreras-Torres R; Gaborieau V; Brennan P; Bracci PM; Neale RE; Olson SH; Gallinger S; Li D; Petersen GM; Risch HA; Klein AP; Han J; Abnet CC; Freedman ND; Taylor PR; Maris JM; Aben KK; Kiemeney LA; Vermeulen SH; Wiencke JK; Walsh KM; Wrensch M; Rice T; Turnbull C; Litchfield K; Paternoster L; Standl M; Abecasis GR; SanGiovanni JP; Li Y; Mijatovic V; Sapkota Y; Low SK; Zondervan KT; Montgomery GW; Nyholt DR; van Heel DA; Hunt K; Arking DE; Ashar FN; Sotoodehnia N; Woo D; Rosand J; Comeau ME; Brown WM; Silverman EK; Hokanson JE; Cho MH; Hui J; Ferreira MA; Thompson PJ; Morrison AC; Felix JF; Smith NL; Christiano AM; Petukhova L; Betz RC; Fan X; Zhang X; Zhu C; Langefeld CD; Thompson SD; Wang F; Lin X; Schwartz DA; Fingerlin T; Rotter JI; Cotch MF; Jensen RA; Munz M; Dommisch H; Schaefer AS; Han F; Ollila HM; Hillary RP; Albagha O; Ralston SH; Zeng C; Zheng W; Shu XO; Reis A; Uebe S; Hüffmeier U; Kawamura Y; Otowa T; Sasaki T; Hibberd ML; Davila S; Xie G; Siminovitch K; Bei JX; Zeng YX; Försti A; Chen B; Landi S; Franke A; Fischer A; Ellinghaus D; Flores C; Noth I; Ma SF; Foo JN; Liu J; Kim JW; Cox DG; Delattre O; Mirabeau O; Skibola CF; Tang CS; Garcia-Barcelo M; Chang KP; Su WH; Chang YS; Martin NG; Gordon S; Wade TD; Lee C; Kubo M; Cha PC; Nakamura Y; Levy D; Kimura M; Hwang SJ; Hunt S; Spector T; Soranzo N; Manichaikul AW; Barr RG; Kahali B; Speliotes E; Yerges-Armstrong LM; Cheng CY; Jonas JB; Wong TY; Fogh I; Lin K; Powell JF; Rice K; Relton CL; Martin RM; Davey Smith G
JAMA Oncol; 2017 May; 3(5):636-651. PubMed ID: 28241208
[TBL] [Abstract][Full Text] [Related]
11. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
Vodickova L; Horak J; Vodicka P
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):942-948. PubMed ID: 35506247
[TBL] [Abstract][Full Text] [Related]
12. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.
Wong C; Chen F; Alirezaie N; Wang Y; Cuggia A; Borgida A; Holter S; Lenko T; Domecq C; ; Petersen GM; Syngal S; Brand R; Rustgi AK; Cote ML; Stoffel E; Olson SH; Roberts NJ; Akbari MR; Majewski J; Klein AP; Greenwood CMT; Gallinger S; Zogopoulos G
PLoS Genet; 2019 Aug; 15(8):e1008344. PubMed ID: 31469826
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
14. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
[TBL] [Abstract][Full Text] [Related]
15. Familial pancreatic carcinoma in Jews.
Lynch HT; Deters CA; Lynch JF; Brand RE
Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
[TBL] [Abstract][Full Text] [Related]
16. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
Roberts NJ; Grant RC; Gallinger S; Klein AP;
Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.
Campa D; Matarazzi M; Greenhalf W; Bijlsma M; Saum KU; Pasquali C; van Laarhoven H; Szentesi A; Federici F; Vodicka P; Funel N; Pezzilli R; Bueno-de-Mesquita HB; Vodickova L; Basso D; Obazee O; Hackert T; Soucek P; Cuk K; Kaiser J; Sperti C; Lovecek M; Capurso G; Mohelnikova-Duchonova B; Khaw KT; König AK; Kupcinskas J; Kaaks R; Bambi F; Archibugi L; Mambrini A; Cavestro GM; Landi S; Hegyi P; Izbicki JR; Gioffreda D; Zambon CF; Tavano F; Talar-Wojnarowska R; Jamroziak K; Key TJ; Fave GD; Strobel O; Jonaitis L; Andriulli A; Lawlor RT; Pirozzi F; Katzke V; Valsuani C; Vashist YK; Brenner H; Canzian F
Int J Cancer; 2019 Mar; 144(6):1275-1283. PubMed ID: 30325019
[TBL] [Abstract][Full Text] [Related]
18. Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
Campa D; Pastore M; Gentiluomo M; Talar-Wojnarowska R; Kupcinskas J; Malecka-Panas E; Neoptolemos JP; Niesen W; Vodicka P; Delle Fave G; Bueno-de-Mesquita HB; Gazouli M; Pacetti P; Di Leo M; Ito H; Klüter H; Soucek P; Corbo V; Yamao K; Hosono S; Kaaks R; Vashist Y; Gioffreda D; Strobel O; Shimizu Y; Dijk F; Andriulli A; Ivanauskas A; Bugert P; Tavano F; Vodickova L; Zambon CF; Lovecek M; Landi S; Key TJ; Boggi U; Pezzilli R; Jamroziak K; Mohelnikova-Duchonova B; Mambrini A; Bambi F; Busch O; Pazienza V; Valente R; Theodoropoulos GE; Hackert T; Capurso G; Cavestro GM; Pasquali C; Basso D; Sperti C; Matsuo K; Büchler M; Khaw KT; Izbicki J; Costello E; Katzke V; Michalski C; Stepien A; Rizzato C; Canzian F
Oncotarget; 2016 Aug; 7(35):57011-57020. PubMed ID: 27486979
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Genetics.
Amundadottir LT
Int J Biol Sci; 2016; 12(3):314-25. PubMed ID: 26929738
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
Arnes L; Liu Z; Wang J; Maurer C; Sagalovskiy I; Sanchez-Martin M; Bommakanti N; Garofalo DC; Balderes DA; Sussel L; Olive KP; Rabadan R
Gut; 2019 Mar; 68(3):499-511. PubMed ID: 29440233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
